Medical specialists from France tagged as investigators in clinical trials studying Polycystic Kidney Diseases

Total 29 results

Angelo Testa, MD
Seen in:
- Reze, ECHO Confluent
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Antoine Durrbach, MD
Seen in:
- Le Kremlin-Bicêtre, Hospital Henri-Mondor AP-HP
Trials:
- NCT03918447 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney;
- ADPKD
Antoine Thierry, MD PhD
Seen in:
- Poitiers, CHU Poitiers
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Bassem Wehbe, MD
Seen in:
- Quimper, CHI de Cournouaille
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Bertrand Knebelmann, MD
Seen in:
- Paris, Hopital Necker, Universite Paris Descartes
Trials:
- NCT03749447 (Principal Investigator)
- NCT03918447 (Principal Investigator)
Conditions:
Christophe Charasse, MD
Seen in:
- Saint Brieuc, CH Yves Le Foll
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Corneliu Savoiu, MD
Seen in:
- Saint Herblain, ECHO Centre Ambulatoire
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Didier Legrand, MD
Seen in:
- Lorient, AUB Lorient
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Dominique Besnier, MD
Seen in:
- Saint Nazaire, CH de Saint Nazaire
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Dominique Chaveau, Prof
Seen in:
- Toulouse, Hôpital de Rangueil
Trials:
- NCT02187432 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Eric Renaudineau, MD
Seen in:
- Saint Malo, CH Saint Malo
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Guillaume Seret, MD
Seen in:
- Le Mans, ECHO dialyse
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Jean Francois Augusto, MD PhD
Seen in:
- Angers, Chu Angers
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Jean Paul Jaulin, MD
Seen in:
- La Roche sur Yon, CH La Roche sur Yon
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Jean Philippe Coindre, MD
Seen in:
- Le Mans, CH Le Mans
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Katell Goulesque, MD
Seen in:
- Brest, Centre Nephrologie et Dialyse d Armorique
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Lucile Figueres, MD
Seen in:
- Nantes, CHU de Nantes
Trials:
- NCT03918447 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney;
- ADPKD
Marin Le Mee, MD
Seen in:
- Morlaix, AUB Morlaix
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Maryvonne Hourmand, MD PhD
Seen in:
- Nantes, CHU Nantes
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Mathias Buchler, MD PhD
Seen in:
- Tours, Chu Tours
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Philippe Jousset, MD
Seen in:
- Pontivy, CH Centre Bretagne
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Philippe Zaoui, MD
Seen in:
- Grenoble, CHU Grenoble Alpes
Trials:
- NCT03749447 (Principal Investigator)
- NCT03918447 (Principal Investigator)
Conditions:
Regine Perrichot, MD
Seen in:
- Vannes, CH Bretagne Atlantique
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Seddik Benarbia, MD
Seen in:
- Quimper, AUB Quimper
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Sonia Mzoughi, MD
Seen in:
- Roscoff, Centre Heliomarin de Roscoff
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Theophile Sawadogo, MD
Seen in:
- Lorient, CH Bretagne Sud
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Victorio Menoyo, MD
Seen in:
- Vannes, ECHO Vannes
Trials:
- NCT02887729 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Yannick Le Meur, Prof
Seen in:
- Brest, Centre Hospitalier Universitaire de Brest
Trials:
- NCT02187432 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney Disease
Yannick LeMeur, MD
Seen in:
- Brest, University Hospital La Cavale Blanche
Trials:
- NCT03918447 (Principal Investigator)
Conditions:
- Autosomal Dominant Polycystic Kidney;
- ADPKD

Clinical Trials on Polycystic Kidney Diseases

Palladio Biosciences
Centessa Pharmaceuticals plc

Terminated

Safety of Lixivaptan in Subjects Previously Treated With Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ALERT)

ADPKD | Polycystic Kidney Disease, Adult

United States
Emory University
PKD Foundation

Completed

ADPKD Cohort Study

Autosomal Dominant Polycystic Kidney Disease

United States
Kadmon Corporation, LLC

Terminated

Long-Term Treatment and Follow up of Subjects Completing 24 Months of Treatment With Tesevatinib on Study KD019-101

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

United States
Kyorin University

Unknown

Efficacy of Tolvaptan on ADPKD Patients

Autosomal Dominant Polycystic Kidney Disease

Japan
University of North Carolina, Chapel Hill
National Institute of General Medical Sciences (NIGMS)

Completed

ADPKD Alterations in Hepatic Transporter Function

Renal Disease | Autosomal Dominant Polycystic Kidney Disease | ADPKD

United States
Assistance Publique - Hôpitaux de Paris
IPSEN pharmaceutical company, Boulogne-Billancourt, France

Completed

Lanreotide In Polycystic Kidney Disease Study (LIPS)

Autosomal Dominant Polycystic Kidney Disease (ADPKD

France
Cambridge University Hospitals NHS Foundation Trust
Addenbrookes Charitable Trust; PKD Charity; British Renal Society & British Kidney...

Completed

High Water Intake in Polycystic Kidney Disease (DRINK)

Autosomal Dominant Polycystic Kidney Disease

United Kingdom
University of Pittsburgh
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...

Completed

Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP II)

Autosomal Dominant Polycystic Kidney Disease

United States
Andreas L. Serra

Unknown

The Eurocyst Initiative: Building a Network of ADPKD Reference Centers Across Europe

Autosomal Dominant Polycystic Kidney Disease

France, Switzerland, Germany, Netherlands, Belgium, Czech Republic, Italy, Spain, Turkey, United Kingdom
Mario Negri Institute for Pharmacological Research
Otsuka Pharmaceutical Italy S.r.l.

Completed

Tolvaptan-Octreotide LAR Combination in ADPKD (TOOL)

Autosomal Dominant Polycystic Kidney Disease

Italy

Medical specialists from France tagged as investigators in clinical trials studying Polycystic Kidney Diseases

Clinical Trials on Polycystic Kidney Diseases

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations